介入放射学CT引导下经皮微波消融治疗肾细胞癌:评估评分系统的效能(DOI:10.19300/j.2024.e1101)。Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma:evaluating the performance of nephrometry s...介入放射学CT引导下经皮微波消融治疗肾细胞癌:评估评分系统的效能(DOI:10.19300/j.2024.e1101)。Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma:evaluating the performance of nephrometry scores(DOI:10.1007/s00330-023-09774-y)E.Efthymiou,G.Velonakis,G.Charalampopoulos,A.Mazioti,E.Brountzos,N.Kelekis,et al.摘要目的旨在评估RENAL和改良RENAL(mRENAL)评分在预测接受微波消融(MWA)治疗的T1期肾细胞癌(RCC)病人预后中的作用。方法回顾性纳入经活检证实为T1a(84%)或T1b(16%)期的孤立性RCC病人76例,所有病人均行CT引导下MWA。通过计算RENAL和mRENAL评分来评估肿瘤的复杂性。结果大多数病变为外凸性(82.9%),距集合系统>7 mm(53.9%),位于背侧(73.6%),位于极线以下(61.8%)。展开更多
